Search

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies. 

The Ethiopian private health sector is growing in size and scope. Over one-third of Ethiopian health expenditures go to private providers but the quality and availability of private providers’ priority health services is uneven. The government’s plans…

This report from Abt and Anlar finds correlations between meeting with a high school counselor, FAFSA completion, and receipt of need-based grants for college.

The Family and Medical Leave Act (FMLA) guarantees eligible U.S. employees of covered employers job-protected unpaid leave to attend to their or their family’s eligible medical issues. Employees may have access to pay while on leave through other means…

Abt is evaluating if new approaches to CMS’s Integrated Care for Kids (InCK) Model can improve outcomes for Medicaid-enrolled children while controlling costs.

In this blog, Abt’s James White outlines what it might take to create resilient supply chains that can function unimpeded during crises such as COVID-19.

Abt offers three tips to help states set up a quality rating system for their Medicaid and CHIP managed care programs.

Ethiopia illustrates the potential of public-private partnerships to expand equitable access to medicines and other health care services.

Sickle cell disease (SCD) is an inherited blood condition that affects an estimated 100,000 individuals in the United States, many of whom are Black and Hispanic Americans. While newborn screening for SCD occurs in every state, there…